Nikiforovich G.V., Zhang M., Yang Q., Jagadeesh G., Chen H.C., Hunyady L., Marshall G.R., & Catt K.J. (2006). “Interactions between conserved residues in transmembrane helices 2 and 7 during angiotensin AT1 receptor activation.” Chem Biol Drug Des. 2006 Nov;68(5):239-49. (Abstract)
Downs M.A., Arimoto R., Marshall G.R., & Kisselev O.G. (2006). “G-protein alpha and beta-gamma subunits interact with conformationally distinct signaling states of rhodopsin.” Vision Res. 2006 Dec;46(27):4442-8. Epub 2006 Sep 20. (Abstract)
Nikiforovich G.V. & Marshall G.R. (2006). “3D modeling of the activated states of constitutively active mutants of rhodopsin.” Biochem Biophys Res Commun. 2006 Jun 23;345(1):430-7. Epub 2006 Apr 25. (Abstract)
Anderson M.A., Ogbay B., Arimoto R., Sha W., Kisselev O.G., Cistola D.P., & Marshall G.R. (2006). “Relative strength of cation-pi vs salt-bridge interactions: the Gtalpha(340-350) peptide/rhodopsin system.” J Am Chem Soc. 2006 Jun 14;128(23):7531-41. (Abstract)
Våbenø J., Nikiforovich G.V., & Marshall G.R. (2006). “Insight into the binding mode for cyclopentapeptide antagonists of the CXCR4 receptor.” Chem Biol Drug Des. 2006 May;67(5):346-54. (Abstract)
Ye Y., Liu M., Kao J.L., & Marshall G.R. (2006). “Novel trihydroxamate-containing peptides: design, synthesis, and metal coordination.” Biopolymers. 2006;84(5):472-89. (Abstract)
Che Y. & Marshall G.R. (2006). “Impact of cis-proline analogs on peptide conformation.” Biopolymers. 2006 Apr 5;81(5):392-406. (Abstract)
Våbenø J., Nikiforovich G.V., & Marshall G.R. (2006). “A minimalistic 3D pharmacophore model for cyclopentapeptide CXCR4 antagonists.” Biopolymers. 2006;84(5):459-71. (Abstract)
Che Y., Brooks B.R., & Marshall G.R. (2006). “Development of small molecules designed to modulate protein-protein interactions.” J Comput Aided Mol Des. 2006 Feb;20(2):109-30. Epub 2006 Apr 19. (Abstract)